A Solari1. 1. Unit of Neuroepidemiology, Foundation IRCCS Neurological Institute C. Besta, Via Celoria 11, 20133, Milan, Italy. alessandra.solari@istituto-besta.it.
Unfortunately, the original version of this article [1] contained an error. The correct paragraph can be found below:SEIQoL-DW: a sample size of 21 patients assigned to HPA (study intervention) and 11 assigned to UC (control) has a power of 80% to detect an assumed mean change of score of 12.1 (standard deviation (SD) 12.8) in the HPA group compared to a change of -7.4 (SD 19.3) (null hypothesis) in the UC group, at alpha level 0.05 using a two-sided, two-sample t test. Assuming 20% dropout, 25 patients are required in the HPA group and 13 in the UC group (total sample size 38).
Authors: Alessandra Solari; Andrea Giordano; Maria Grazia Grasso; Paolo Confalonieri; Francesco Patti; Alessandra Lugaresi; Lucia Palmisano; Roberta Amadeo; Giovanni Martino; Michela Ponzio; Giuseppe Casale; Claudia Borreani; Renzo Causarano; Simone Veronese; Paola Zaratin; Mario Alberto Battaglia Journal: Trials Date: 2015-04-23 Impact factor: 2.279